Daily News Podcast

Lorcaserin shows cardiovascular safety

Publish date: August 27, 2018

 

Lorcaserin is the first weight-loss drug proven to have cardiovascular safety. Also today, live attenuated flu vaccine gets the nod for upcoming flu season, PCSK9 inhibition helps patients with metabolic syndrome, and breastfeeding may reduce the risk of stroke decades later. Subscribe to the MDedge Daily News wherever you get your podcasts.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Adult congenital heart disease guideline gets 10-year update, new classification system
MDedge Cardiology
New guidelines remap adult congenital heart disease
MDedge Cardiology
Cardiovascular risk management supported for type 2 diabetes
MDedge Cardiology
Open AAA and peripheral bypass surgery patients among the highest users of post-acute care
MDedge Cardiology
An epidemic of non-alcoholic fatty liver disease
MDedge Cardiology
Sleepio app tied to reducing insomnia, depression
MDedge Cardiology
5 digital HIPAA myths
MDedge Cardiology
Screen for cervical cancer based on age, risk
MDedge Cardiology
Breastfeeding linked with lower risk of stroke later in life
MDedge Cardiology
Is it time for PCPs to take over chronic HCV?
MDedge Cardiology